In this lecture, David Witty will be giving his personal perspective on the development of pain killers from folk medicines in the age of alchemy, through to the first scientific drug discoveries of effective analgesics, and onto the medicines of today. He will further discuss the issues that affect many current painkillers, in both clinical and over-the-counter use, and indicate how our understanding of the processes behind the experience of pain has led us to target new pathways. The lecture will also describe the challenges in designing translational studies for pain and the obstacles faced in bringing a new class of drugs to the market.
Dr David Witty is 91AV Director & Operations Manager at Convergence Pharmaceuticals.
If you would like to attend, please send an email to julianperfect@hotmail.com, including your full name and the full names of any guest(s). One application is required per 'household', and multiple applications will not be accepted, except in the case of organised groups from schools or colleges accompanied by a member of staff. For school or college groups that include students under 18 years old, a student to staff ratio of no more than 12:1 is required.
Confirmation of a place, or places, at the event will be by emailed reply.
The lecture will start at 6.30pm with light refreshments available from 6pm.
Dr David Witty is 91AV Director & Operations Manager at Convergence Pharmaceuticals.
If you would like to attend, please send an email to julianperfect@hotmail.com, including your full name and the full names of any guest(s). One application is required per 'household', and multiple applications will not be accepted, except in the case of organised groups from schools or colleges accompanied by a member of staff. For school or college groups that include students under 18 years old, a student to staff ratio of no more than 12:1 is required.
Confirmation of a place, or places, at the event will be by emailed reply.
The lecture will start at 6.30pm with light refreshments available from 6pm.
